Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of a 3-month Individual Reminiscence Therapy Program on Global Cognition, Mood, and Quality of Life in Older Adults With Mild to Moderate Alzheimer's Disease: A Multicenter Randomized Controlled Trial

NCT06812442 is registered in ClinicalTrials.gov with Rsocialform - Geriatria, Lda as lead sponsor.

NCT NCT06812442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06812442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of a 3-month Individual Reminiscence Therapy Program on Global Cognition, Mood, and Quality of Life in Older Adults With Mild to Moderate Alzheimer's Disease: A Multicenter Randomized Controlled Trial
Lead sponsor
Rsocialform - Geriatria, Lda
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2025
Completion date
May 23, 2025
Enrollment
40 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment, dementia